KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Idexx Laboratories (IDXX) over the last 16 years, with Q3 2025 value amounting to $80.6 million.

  • Idexx Laboratories' Shares Outstanding (Weighted Average) fell 250.38% to $80.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.6 million, marking a year-over-year decrease of 250.38%. This contributed to the annual value of $82.5 million for FY2024, which is 72.11% down from last year.
  • Idexx Laboratories' Shares Outstanding (Weighted Average) amounted to $80.6 million in Q3 2025, which was down 250.38% from $80.9 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Shares Outstanding (Weighted Average) high stood at $85.5 million for Q1 2021, and its period low was $80.6 million during Q3 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $83.1 million (2024), whereas its average is $83.4 million.
  • As far as peak fluctuations go, Idexx Laboratories' Shares Outstanding (Weighted Average) increased by 17.0% in 2021, and later plummeted by 250.38% in 2025.
  • Quarter analysis of 5 years shows Idexx Laboratories' Shares Outstanding (Weighted Average) stood at $85.2 million in 2021, then dropped by 1.85% to $83.6 million in 2022, then decreased by 0.67% to $83.1 million in 2023, then dropped by 0.72% to $82.5 million in 2024, then fell by 2.26% to $80.6 million in 2025.
  • Its last three reported values are $80.6 million in Q3 2025, $80.9 million for Q2 2025, and $81.3 million during Q1 2025.